GREGORY N FULLER to Pituitary Neoplasms
This is a "connection" page, showing publications GREGORY N FULLER has written about Pituitary Neoplasms.
Connection Strength
0.977
-
Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol. 2008 Jun; 12(3):199-203.
Score: 0.261
-
Elevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomas. Ann Diagn Pathol. 2005 Feb; 9(1):6-10.
Score: 0.219
-
Treatment and long-term outcomes in pituitary carcinoma: a cohort study. Eur J Endocrinol. 2019 Oct; 181(4):397-407.
Score: 0.151
-
Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas. Pituitary. 2012 Dec; 15(4):556-61.
Score: 0.094
-
Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma. J Neurooncol. 2010 May; 98(1):151-2.
Score: 0.076
-
Metastatic melanoma to the pituitary gland. Can J Neurol Sci. 2007 Aug; 34(3):322-7.
Score: 0.065
-
Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol. 2007 Jul; 17(3):319-24.
Score: 0.065
-
Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus. 2002 May 15; 12(5):e3.
Score: 0.045